ANGN
Angion Biomedica Corp
Price:  
USD
Volume:  
224,845
United States | Pharmaceuticals

ANGN ROE (Return on Equity)

As of 2025-07-14, the ROE (Return on Equity) of Angion Biomedica Corp (ANGN) is -88.7%.

ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.

ANGN ROE (Return on Equity) - Historical Value
DateValue
2022-12-31 -88.7%
2021-12-31 -67%
2020-12-31 88.6%
2019-12-31 218.7%
2018-12-31 -105.9%
-
-
-
-
-
ANGN ROE (Return on Equity) - Peers Comparison